Regional variation in p2 receptor expression in the rat pulmonary arterial circulation

K. Chootip, K.F. Ness, Y. Wang, A.M. Gurney, C. Kennedy

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The P2 receptors that mediate contraction of the rat isolated small (SPA, 200–500 μm i.d.) and large (LPA, 1–1.5 mm i.d.) intrapulmonary arteries were characterized. In endothelium-denuded vessels the contractile order of potency was α,β-methyleneATP (α,β-meATP)>>UDP=UTP=ATP=2-methylthioATP>ADP in the SPA and α,β-meATP=UTPUDP>2-methylthioATP, ATP>>ADP in the LPA. α,β-meATP, 2-methylthioATP and ATP had significantly greater effects in the SPA than the LPA (P<0.001), but there was no difference in the potency of UTP or UDP between the vessels. In the SPA, P2X1 receptor desensitisation by α,β-meATP (100 μm) inhibited contractions to α,β-meATP (10 nm–300 μm), but not those to UTP or UDP (100 nm–300 μm). In the LPA, prolonged exposure to α,β-meATP (100 μm) did not desensitize P2X receptors. Pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), suramin and reactive blue 2 (RB2) (30–300 μm) inhibited contractions evoked by α,β-meATP. UTP and UDP were potentiated by PPADS, unaffected by RB2 and inhibited, but not abolished by suramin. 1 and 3 mm suramin produced no further inhibition, indicating suramin-resistant components in the responses to UTP and UDP. Thus, both P2X and P2Y receptors mediate contraction of rat large and small intrapulmonary arteries. P2Y agonist potency and sensitivity to antagonists were similar in small and large vessels, but P2X agonists were more potent in small arteries. This indicates differential expression of P2X, but not P2Y receptors along the pulmonary arterial tree.
LanguageEnglish
Pages637-646
Number of pages10
JournalBritish Journal of Pharmacology
Volume137
Issue number5
DOIs
Publication statusPublished - 2002

Fingerprint

Uridine Triphosphate
Uridine Diphosphate
Pulmonary Circulation
Suramin
Cibacron Blue F 3GA
Arteries
Adenosine Triphosphate
Adenosine Diphosphate
Purinergic P2X1 Receptors
Acids
Endothelium
Lung

Keywords

  • pulmonary artery
  • P2Y receptors
  • P2X receptors

Cite this

Chootip, K. ; Ness, K.F. ; Wang, Y. ; Gurney, A.M. ; Kennedy, C. / Regional variation in p2 receptor expression in the rat pulmonary arterial circulation. In: British Journal of Pharmacology. 2002 ; Vol. 137, No. 5. pp. 637-646.
@article{95f7804b0d5c4f9ea89c6663ec6ea914,
title = "Regional variation in p2 receptor expression in the rat pulmonary arterial circulation",
abstract = "The P2 receptors that mediate contraction of the rat isolated small (SPA, 200–500 μm i.d.) and large (LPA, 1–1.5 mm i.d.) intrapulmonary arteries were characterized. In endothelium-denuded vessels the contractile order of potency was α,β-methyleneATP (α,β-meATP)>>UDP=UTP=ATP=2-methylthioATP>ADP in the SPA and α,β-meATP=UTPUDP>2-methylthioATP, ATP>>ADP in the LPA. α,β-meATP, 2-methylthioATP and ATP had significantly greater effects in the SPA than the LPA (P<0.001), but there was no difference in the potency of UTP or UDP between the vessels. In the SPA, P2X1 receptor desensitisation by α,β-meATP (100 μm) inhibited contractions to α,β-meATP (10 nm–300 μm), but not those to UTP or UDP (100 nm–300 μm). In the LPA, prolonged exposure to α,β-meATP (100 μm) did not desensitize P2X receptors. Pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), suramin and reactive blue 2 (RB2) (30–300 μm) inhibited contractions evoked by α,β-meATP. UTP and UDP were potentiated by PPADS, unaffected by RB2 and inhibited, but not abolished by suramin. 1 and 3 mm suramin produced no further inhibition, indicating suramin-resistant components in the responses to UTP and UDP. Thus, both P2X and P2Y receptors mediate contraction of rat large and small intrapulmonary arteries. P2Y agonist potency and sensitivity to antagonists were similar in small and large vessels, but P2X agonists were more potent in small arteries. This indicates differential expression of P2X, but not P2Y receptors along the pulmonary arterial tree.",
keywords = "pulmonary artery, P2Y receptors, P2X receptors",
author = "K. Chootip and K.F. Ness and Y. Wang and A.M. Gurney and C. Kennedy",
year = "2002",
doi = "10.1038/sj.bjp.0704915",
language = "English",
volume = "137",
pages = "637--646",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
number = "5",

}

Regional variation in p2 receptor expression in the rat pulmonary arterial circulation. / Chootip, K.; Ness, K.F.; Wang, Y.; Gurney, A.M.; Kennedy, C.

In: British Journal of Pharmacology, Vol. 137, No. 5, 2002, p. 637-646.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regional variation in p2 receptor expression in the rat pulmonary arterial circulation

AU - Chootip, K.

AU - Ness, K.F.

AU - Wang, Y.

AU - Gurney, A.M.

AU - Kennedy, C.

PY - 2002

Y1 - 2002

N2 - The P2 receptors that mediate contraction of the rat isolated small (SPA, 200–500 μm i.d.) and large (LPA, 1–1.5 mm i.d.) intrapulmonary arteries were characterized. In endothelium-denuded vessels the contractile order of potency was α,β-methyleneATP (α,β-meATP)>>UDP=UTP=ATP=2-methylthioATP>ADP in the SPA and α,β-meATP=UTPUDP>2-methylthioATP, ATP>>ADP in the LPA. α,β-meATP, 2-methylthioATP and ATP had significantly greater effects in the SPA than the LPA (P<0.001), but there was no difference in the potency of UTP or UDP between the vessels. In the SPA, P2X1 receptor desensitisation by α,β-meATP (100 μm) inhibited contractions to α,β-meATP (10 nm–300 μm), but not those to UTP or UDP (100 nm–300 μm). In the LPA, prolonged exposure to α,β-meATP (100 μm) did not desensitize P2X receptors. Pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), suramin and reactive blue 2 (RB2) (30–300 μm) inhibited contractions evoked by α,β-meATP. UTP and UDP were potentiated by PPADS, unaffected by RB2 and inhibited, but not abolished by suramin. 1 and 3 mm suramin produced no further inhibition, indicating suramin-resistant components in the responses to UTP and UDP. Thus, both P2X and P2Y receptors mediate contraction of rat large and small intrapulmonary arteries. P2Y agonist potency and sensitivity to antagonists were similar in small and large vessels, but P2X agonists were more potent in small arteries. This indicates differential expression of P2X, but not P2Y receptors along the pulmonary arterial tree.

AB - The P2 receptors that mediate contraction of the rat isolated small (SPA, 200–500 μm i.d.) and large (LPA, 1–1.5 mm i.d.) intrapulmonary arteries were characterized. In endothelium-denuded vessels the contractile order of potency was α,β-methyleneATP (α,β-meATP)>>UDP=UTP=ATP=2-methylthioATP>ADP in the SPA and α,β-meATP=UTPUDP>2-methylthioATP, ATP>>ADP in the LPA. α,β-meATP, 2-methylthioATP and ATP had significantly greater effects in the SPA than the LPA (P<0.001), but there was no difference in the potency of UTP or UDP between the vessels. In the SPA, P2X1 receptor desensitisation by α,β-meATP (100 μm) inhibited contractions to α,β-meATP (10 nm–300 μm), but not those to UTP or UDP (100 nm–300 μm). In the LPA, prolonged exposure to α,β-meATP (100 μm) did not desensitize P2X receptors. Pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), suramin and reactive blue 2 (RB2) (30–300 μm) inhibited contractions evoked by α,β-meATP. UTP and UDP were potentiated by PPADS, unaffected by RB2 and inhibited, but not abolished by suramin. 1 and 3 mm suramin produced no further inhibition, indicating suramin-resistant components in the responses to UTP and UDP. Thus, both P2X and P2Y receptors mediate contraction of rat large and small intrapulmonary arteries. P2Y agonist potency and sensitivity to antagonists were similar in small and large vessels, but P2X agonists were more potent in small arteries. This indicates differential expression of P2X, but not P2Y receptors along the pulmonary arterial tree.

KW - pulmonary artery

KW - P2Y receptors

KW - P2X receptors

U2 - 10.1038/sj.bjp.0704915

DO - 10.1038/sj.bjp.0704915

M3 - Article

VL - 137

SP - 637

EP - 646

JO - British Journal of Pharmacology

T2 - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 5

ER -